BUZZ-Sana Biotechnology rises as cell transplant shows promise in type 1 diabetes treatment
Reuters03-13 21:15
BUZZ-<a href="https://laohu8.com/S/SANA">Sana Biotechnology</a> rises as cell transplant shows promise in type 1 diabetes treatment
** Shares of biotech firm Sana Biotechnology SANA.O rise 5.2% to $3.25 premarket
** Co said an experimental cell transplant for type 1 diabetes showed insulin production for 14 months without immune‑suppressing drugs
** Type 1 diabetes is an autoimmune disease where the body destroys insulin‑making cells, forcing patients to rely on injections
** Co says transplanted insulin‑producing cells survived, avoided immune attack and released insulin in response to meals, based on C‑peptide data
** Study used a low dose to test safety and cell function; no safety issues were seen, co says
** Shares up about threefold in 2025
(Reporting by Sahil Pandey in Bengaluru)
((Sahil.Pandey@thomsonreuters.com))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments